Document is current
Any future updates will be listed below
-
Authors
Zhang, Heng
Zhao, Tong
Ding, Jiangyi
Wang, Ziyi
Cao, Nannan
Zhang, Sai
Xie, Kai
Sun, Jiawei
Gao, Liugang
Li, Xiaoqin
Ni, Xinye
-
Funding
Funding for this research was provided by:
Jiangsu Provincial Medical Key Discipline Construction Unit (Oncology Therapeutics (JSDW202237)
Social Development Project of Jiangsu Provincial Key Research & Development Plan (BE2022720)
General Project of Jiangsu Provincial Health Commission (M2020006)
Natural Science Research of Jiangsu Higher Education Institutions of China (BK20231190)
Changzhou Social Development Project (CE20235063)
National Natural Science Foundation of China (62371243)
- License Information
-
More Information
Article History
Received: 16 July 2024
Accepted: 12 November 2024
First Online: 21 November 2024
Declarations
:
: This retrospective study was approved by the Ethics Committee of the Affiliated Nanjing Medical University Changzhou Second People’s Hospital (approval number: [2020]KY154-01) and the requirement for informed consent from all patients was waived.
: The authors declare no competing interests.
